ZEVRA THERAPEUTICS, INC.
ZVRA$505M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCELEBRATION59 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ZVRA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
KP415 oral capsule | Phase 3 | ADHD | - | - |
Serdexmethylphenidate | Phase 2 | Idiopathic Hypersomnia | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply